Polomar Health Services, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Polomar Health Services, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2023
FY2024
FY2025
Revenue
0.03
0.04
0.06
0.65
Cost of revenue
0
0.03
0.19
Gross profit
0.03
0.04
0.03
0.46
Selling and marketing
0.03
0.05
0.07
General and administrative
0.22
0.45
1.28
10.9
Operating expenses
0.22
0.48
1.33
11
Operating income
-0.18
-0.44
-1.3
-10.6
Interest expense
0
0.04
0.15
Other non-operating income
0
-0.15
-0.04
-0.15
Net income
-0.18
-0.59
-1.34
-10.7
EBITDA
-0.43
-1.04
-0.78
EPS, basic
0.00
-0.02
-0.05
-0.39
EPS, diluted
0.00
-0.02
-0.05
-0.39
Shares, basic (weighted)
453
26.1
27.7
27.8
Shares, diluted (weighted)
453
26.1
27.7
27.8
Balance sheet
FY2023
FY2023
FY2024
FY2025
Cash and equivalents
0.23
0
0.01
0.13
Receivables
0.03
Inventory
0
0.07
0.09
Other current assets
0.01
Total current assets
0.26
0.01
0.08
0.32
Property, plant and equipment
0.08
0.04
Lease right-of-use assets
0.08
0.05
0.01
Other non-current assets
0.09
9.79
0.02
Total assets
0.26
0.11
9.95
0.39
Accounts payable
0.01
0.04
0.16
0.39
Deferred revenue
0.3
Short-term debt
0.03
Total current liabilities
0.07
0.1
1.34
1.61
Lease liabilities
0.05
0.01
Total liabilities
0.07
0.15
1.35
1.61
Paid-in capital
1.02
1.28
11.5
12.4
Retained earnings
-0.98
-1.57
-2.91
-13.6
Shareholders' equity
0.19
-0.04
8.6
-1.22
Total equity
0.19
-0.04
8.6
-1.22
Total liabilities and equity
0.26
0.11
9.95
0.39
Shares outstanding
108
27.7
27.7
28
Cash flow statement
FY2023
FY2023
FY2024
FY2025
Net income
-0.18
-0.59
-1.34
-10.7
Depreciation and amortization
0.01
0.26
9.77
Stock-based compensation
0.17
0.13
Change in receivables
-0.03
0.03
-0
-0.1
Change in inventory
-0.07
-0.02
Change in payables
0
0.01
0.13
0.22
Cash from operations
-0.04
-0.53
-1.02
-0.4
Capital expenditures
-0.09
Cash from investing
-0.09
Stock issued
0.23
0.22
Cash from financing
0.27
0.32
1.11
0.52
Net change in cash
0.23
-0.22
-0
0.13
Free cash flow
-1.11
Interest paid
0
0.04
0.15
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.17 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
61.1%
Gross profit / revenue.
Operating margin
-295.0%
Operating income / revenue.
EBITDA margin
-2.7%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-298.3%
Net income / revenue.
Operating cash flow margin
-0.2%
Cash from operations / revenue.
Return on assets (ROA)
-1,162.0%
Net income / average total assets.
D&A / revenue
292.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
1,002.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
165.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
1,389.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
137.1%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
-114.2%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-96.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
14.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
0.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-60.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.11
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.04
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.52x
Market cap / revenue.
EV/Sales
1.46x
Enterprise value / revenue.
Earnings yield
-196.1%
Net income / market cap (the inverse of P/E).
What was Polomar Health Services, Inc.'s revenue in fiscal 2025?
Polomar Health Services, Inc. reported revenue of $648.2K for fiscal 2025, 1,002% higher than the year before.
Was Polomar Health Services, Inc. profitable in fiscal 2025?
No. It reported a net loss of $10.7M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.